On Tuesday, Guardant Health Inc (NASDAQ: GH) opened lower -3.57% from the last session, before settling in for the closing price of $22.94. Price fluctuations for GH have ranged from $15.81 to $37.04 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 49.27% over the past five years. Company’s average yearly earnings per share was noted 23.74% at the time writing. With a float of $116.90 million, this company’s outstanding shares have now reached $121.63 million.
Let’s look at the performance matrix of the company that is accounted for 1779 employees.
Guardant Health Inc (GH) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Diagnostics & Research industry is another important factor to consider. The insider ownership of Guardant Health Inc is 4.97%, while institutional ownership is 95.49%. The most recent insider transaction that took place on Jun 04 ’24, was worth 2,787. In this transaction Director of this company sold 100 shares at a rate of $27.87, taking the stock ownership to the 4,621 shares. Before that another transaction happened on Mar 18 ’24, when Company’s Chief Information Officer bought 2,187 for $17.82, making the entire transaction worth $38,963. This insider now owns 12,722 shares in total.
Guardant Health Inc (GH) Latest Financial update
If we go through the results of last quarter, which was made public on 6/30/2024, the company posted -0.73 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.94) by 0.21. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.72 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 23.74% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 29.20% during the next five years compared to -8.88% drop over the previous five years of trading.
Guardant Health Inc (NASDAQ: GH) Trading Performance Indicators
Check out the current performance indicators for Guardant Health Inc (GH). In the past quarter, the stock posted a quick ratio of 6.07. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.23.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.09, a number that is poised to hit -0.75 in the next quarter and is forecasted to reach -2.85 in one year’s time.
Technical Analysis of Guardant Health Inc (GH)
Guardant Health Inc (NASDAQ: GH) saw its 5-day average volume 1.42 million, a negative change from its year-to-date volume of 2.11 million. As of the previous 9 days, the stock’s Stochastic %D was 17.00%. Additionally, its Average True Range was 1.28.
During the past 100 days, Guardant Health Inc’s (GH) raw stochastic average was set at 21.60%, which indicates a significant increase from 7.82% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 48.35% in the past 14 days, which was lower than the 66.71% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $27.67, while its 200-day Moving Average is $24.59. Nevertheless, the first resistance level for the watch stands at $22.77 in the near term. At $23.43, the stock is likely to face the second major resistance level. The third major resistance level sits at $23.97. If the price goes on to break the first support level at $21.58, it is likely to go to the next support level at $21.04. The third support level lies at $20.39 if the price breaches the second support level.
Guardant Health Inc (NASDAQ: GH) Key Stats
There are currently 122,369K shares outstanding in the company with a market cap of 2.72 billion. Presently, the company’s annual sales total 563,950 K according to its annual income of -479,450 K. Last quarter, the company’s sales amounted to 177,240 K and its income totaled -102,630 K.
